BRIEF-Aralez Pharmaceuticals' drug BLEXTEN receives Health Canada approval

* Aralez pharmaceuticals says Health Canada approved BLEXTEN for treatment of symptoms of seasonal allergic rhinitis, chronic spontaneous urticaria
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.